Hypertension: An Important But Reversible Cause of Systolic Dysfunction in a Cohort of Pediatric Patients

Alicia M Kamsheh1,2, Kevin E Meyers3, Robert A Palermo4

  • 1Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA. alicia.kamsheh@gmail.com.

Pediatric Cardiology
|October 26, 2023
PubMed

Insights

Pediatric cardiac dysfunction due to hypertension (CDHTN) is often reversible, especially in infants. Most children recover function with appropriate management, showing low rates of severe outcomes like heart transplant.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Hypertension Management

Background:

  • Cardiac dysfunction due to hypertension (CDHTN) in children is not well-characterized.
  • Understanding presentation and outcomes is crucial for pediatric cardiovascular health.
  • Identifying factors influencing recovery can optimize treatment strategies.

Purpose of the Study:

  • To describe the clinical presentation and outcomes of pediatric CDHTN.
  • To identify clinical features associated with the resolution of cardiac dysfunction in children with hypertension.
  • To evaluate the impact of hypertension on pediatric cardiac function.

Main Methods:

  • Retrospective cohort study of pediatric patients (≤21 years) with CDHTN (Jan 2005-Sep 2020).
  • Inclusion criteria: systolic dysfunction without other causes, BP >95th percentile, and physician-judged hypertension-related dysfunction.
  • Statistical analysis included Fisher's exact, Mann-Whitney U tests, and multiple correspondence analysis.

Main Results:

  • Thirty-four pediatric patients analyzed; 12 <1 year and 22 ≥1 year.
  • Hypertension causes varied by age: renovascular disease in infants (42%), medical renal disease in older children (77%).
  • Most patients (81%) showed resolution of cardiac dysfunction, particularly infants (92%), with low mortality and no need for mechanical circulatory support or transplantation.

Conclusions:

  • Hypertension is a significant, yet reversible, cause of systolic dysfunction in children.
  • Pediatric patients with CDHTN generally experience good recovery outcomes.
  • Further research is needed to identify specific clinical features predicting dysfunction resolution.

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
14
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
14
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
15
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
595